Roche Diagnostics Operations, Inc. recalls Cobas c Bilirubin Total Gen.3 Catalog Number: 05795419190 - Product Usage: In vitro test for the quantitative determina…
- Recall date
- September 11, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0153-2020
- FDA classification
- Class III
- Brand / firm
- Roche Diagnostics Operations, Inc.
- Sold / distributed
- US Nationwide distribution including the states of AL, AZ, CA, CT, FL, GA, HI, IA, IL, IN, KY, LA, MA, MD, MI, MO, NE, NH, NJ, NY, OH, OK, PA, PR, RI, SC, TN, TX, UT, VA and WI. Updated as of 12/20/19 to include the following additional US states: CO.
Why it was recalled
Due to low Quality Control recovery and invalid Calibration.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Cobas c Bilirubin Total Gen.3 Catalog Number: 05795419190 - Product Usage: In vitro test for the quantitative determination of the total bilirubin in serum and plasma of adults and neonates on Roche/Hitachi cobas c systems.
Get recall alerts
Free email alert whenever Roche Diagnostics Operations, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Roche Diagnostics Operations, Inc.